Drug intelligence / Profile preview

adenoviral c-Maf vector

Development stage
Preclinical
Lead developer
Weill Cornell Medicine
Modality
Gene Therapies
01

Overview

Adenoviral c-Maf vector is an experimental gene therapy vector designed for the constitutive expression of the transcription factor c-Maf (musculoaponeurotic fibrosarcoma oncogene homolog). Developed by researchers at Weill Cornell Medicine, the vector is utilized to engineer naive endothelial cells into functional liver sinusoidal endothelial cells (LSECs) under three-dimensional culture conditions. By inducing a sinusoidal transcriptional program, the c-Maf-expressing LSECs adopt a distinct morphology with open intercellular spaces that recapitulate hepatic sinusoidal architecture. This platform is being investigated for modeling liver diseases, studying endothelial-hepatocyte crosstalk, and as a potential cell therapy strategy involving the transplantation of vascularized hepatocyte organoids to promote rapid revascularization in acute liver failure.

Other names
c-Maf adenoviral vectorc-Maf adenovirus
02

Targets

CXADR (Coxsackievirus and adenovirus receptor)

Beyond the preview

Go deeper on adenoviral c-Maf vector.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adenoviral c-Maf vector.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call